about
Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in IndiaHepatitis B virus and hepatitis C virus infection in healthcare workersFeasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.Biochemistry, physiology, and complications of blood doping: facts and speculation.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Transfusion Transmitted Infections in Armed Forces: Prevalence and Trends.A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt?High prevalence of HIV p24 antigen among HIV antibody negative prospective blood donors in Ile-Ife, Nigeria.Thawed solvent/detergent-treated plasma: too precious to be wasted after 6 hours?Risk factors for hepatitis C virus infection in Inland Brazil: an analysis of pooled epidemiological sectional studies.Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.Hepatitis C virus: Morphogenesis, infection and therapy.Globalization of Infectious Diseases: The Impact of MigrationResidual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives
P2860
Q26752681-38E76170-A5F6-4EF7-969E-33AE2591D562Q26765801-8572BA2F-3567-4148-A130-FD22EF902CFDQ33450364-A3AD4935-1E13-4C83-A5E5-AE6E3A6037ECQ33953427-9DA121B7-9548-4869-ADA2-596FB7CAC2B9Q36504354-B3823313-28E9-4DCC-BC96-6F771511D35FQ37100261-2688CFC2-0308-40C1-99ED-3EC81CAC024DQ37277759-898882D0-C01E-4BB9-A295-858548895D00Q38007308-06696080-D709-47F1-8A1B-58AFB67CB747Q38987518-AF784A92-9FB1-4C9A-BD7C-4F185C80B915Q39860142-BAD35068-A133-43A7-8DC8-630EDB4110B7Q41889128-3CA3A472-85FB-4214-B861-68C0462280F0Q42978514-F5C4D18A-8648-4FD2-8CE5-58ADF95EE53CQ43031733-C316CBDD-2516-4347-A501-907515DEF27DQ52661702-E0677A5F-D2CD-4AC9-A457-D8842105FC47Q56602134-4DF24FB3-23A2-4842-9A80-499951EE6A63Q58999805-AA5BB849-B0DC-484F-A3A2-1825151331AB
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Risks of transfusion-transmitted infections: 2003.
@ast
Risks of transfusion-transmitted infections: 2003.
@en
type
label
Risks of transfusion-transmitted infections: 2003.
@ast
Risks of transfusion-transmitted infections: 2003.
@en
prefLabel
Risks of transfusion-transmitted infections: 2003.
@ast
Risks of transfusion-transmitted infections: 2003.
@en
P2093
P1476
Risks of transfusion-transmitted infections: 2003.
@en
P2093
Edward L Snyder
Gregory J Pomper
P304
P356
10.1097/00062752-200311000-00003
P577
2003-11-01T00:00:00Z